168 related articles for article (PubMed ID: 32111792)
1. The Influence of the Preoperative Status on the Risk of Postoperative Complications After Cytoreductive Surgery for Advanced-stage Ovarian Cancer.
Bacalbasa N; Balescu I; Dimitriu M; Iliescu L; Diaconu C; Dima S; Vilcu M; Brezean I
In Vivo; 2020; 34(2):839-844. PubMed ID: 32111792
[TBL] [Abstract][Full Text] [Related]
2. Visceral obesity and muscle mass determined by CT scan and surgical outcome in patients with advanced ovarian cancer. A retrospective cohort study.
Heus C; Smorenburg A; Stoker J; Rutten MJ; Amant FCH; van Lonkhuijzen LRCW
Gynecol Oncol; 2021 Jan; 160(1):187-192. PubMed ID: 33393479
[TBL] [Abstract][Full Text] [Related]
3. Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications.
Uccella S; Mele MC; Quagliozzi L; Rinninella E; Nero C; Cappuccio S; Cintoni M; Gasbarrini A; Scambia G; Fagotti A
Gynecol Oncol; 2018 May; 149(2):263-269. PubMed ID: 29550182
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of bowel involvement in optimally cytoreduced advanced ovarian cancer: a retrospective study.
Giorda G; Gadducci A; Lucia E; Sorio R; Bounous VE; Sopracordevole F; Tinelli A; Baldassarre G; Campagnutta E
J Ovarian Res; 2014 Jul; 7():72. PubMed ID: 25328074
[TBL] [Abstract][Full Text] [Related]
5. Results of Primary Cytoreductive Surgery in Advanced-stage Epithelial Ovarian Cancer: A Single-center Experience.
Bacalbasa N; Dima S; Balescu I; David L; Brasoveanu V; Popescu I
Anticancer Res; 2015 Jul; 35(7):4099-104. PubMed ID: 26124361
[TBL] [Abstract][Full Text] [Related]
6. Association of Diaphragmatic Surgery as Part of Cytoreductive Effort in Advanced Stage Ovarian Cancer.
Bacalbasa N; Balescu I; Balalau C; Ionescu O; Stoica C
In Vivo; 2018; 32(2):431-436. PubMed ID: 29475933
[TBL] [Abstract][Full Text] [Related]
7. Unplanned postoperative intensive care unit admission for ovarian cancer cytoreduction is associated with significant decrease in overall survival.
Ross MS; Burriss ME; Winger DG; Edwards RP; Courtney-Brooks M; Boisen MM
Gynecol Oncol; 2018 Aug; 150(2):306-310. PubMed ID: 29929924
[TBL] [Abstract][Full Text] [Related]
8. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
[TBL] [Abstract][Full Text] [Related]
9. Unanticipated 30-day readmission following rectosigmoid resection at the time of cytoreductive surgery in patients with advanced stage ovarian cancer.
Sanders BE; Saharti S; Laus K; Bristow RE; Eskander RN
J Obstet Gynaecol; 2021 Aug; 41(6):956-961. PubMed ID: 33228421
[TBL] [Abstract][Full Text] [Related]
10. Rectosigmoidectomy and Douglas Peritonectomy in the Management of Serosal Implants in Advanced-Stage Ovarian Cancer Surgery: Survival and Surgical Outcomes.
Erkilinç S; Karataşli V; Demir B; Çakir İ; Can B; Karadeniz T; Gökçü M; Sanci M
Int J Gynecol Cancer; 2018 Nov; 28(9):1699-1705. PubMed ID: 30371561
[TBL] [Abstract][Full Text] [Related]
11. Predictive Factors for Surgical Morbidities and Adjuvant Chemotherapy Delay for Advanced Ovarian Cancer Patients Treated by Primary Debulking Surgery or Interval Debulking Surgery.
Castro BGR; Dos Reis R; Cintra GF; Sousa MMA; Vieira MA; Andrade CEMDC
Int J Gynecol Cancer; 2018 Oct; 28(8):1520-1528. PubMed ID: 30036229
[TBL] [Abstract][Full Text] [Related]
12. Nomogram for 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.
Nieuwenhuyzen-de Boer GM; Gerestein CG; Eijkemans MJ; Burger CW; Kooi GS
Eur J Gynaecol Oncol; 2016; 37(1):63-8. PubMed ID: 27048112
[TBL] [Abstract][Full Text] [Related]
13. Prediction of suboptimal cytoreductive surgery in patients with advanced ovarian cancer based on preoperative and intraoperative determination of the peritoneal carcinomatosis index.
Llueca A; Serra A; Rivadulla I; Gomez L; Escrig J;
World J Surg Oncol; 2018 Feb; 16(1):37. PubMed ID: 29471831
[TBL] [Abstract][Full Text] [Related]
14. Prediction of 30-day morbidity after primary cytoreductive surgery for advanced stage ovarian cancer.
Gerestein CG; Nieuwenhuyzen-de Boer GM; Eijkemans MJ; Kooi GS; Burger CW
Eur J Cancer; 2010 Jan; 46(1):102-9. PubMed ID: 19900801
[TBL] [Abstract][Full Text] [Related]
15. Is increased chronological age a contraindication to debulking surgery for elderly patients with advanced ovarian cancer?
Park SJ; Mun J; Yim GW; Lee M; Chung HH; Kim JW; Park NH; Song YS; Kim HS
J Obstet Gynaecol; 2022 Oct; 42(7):3254-3259. PubMed ID: 36000804
[TBL] [Abstract][Full Text] [Related]
16. Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center.
Filippova OT; Chi DS; Long Roche K; Sonoda Y; Zivanovic O; Gardner GJ; Tew WP; O'Cearbhaill R; Sarraf S; Sun SW; Alexander K; Korc-Grodzicki B; Shahrokni A
Gynecol Oncol; 2019 Jul; 154(1):77-82. PubMed ID: 31078241
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal molecular subtype is an independent predictor of severe postoperative complications after primary debulking surgery for advanced ovarian cancer.
Torres D; Kumar A; Bakkum-Gamez JN; Weaver AL; McGree ME; Wang C; Langstraat CL; Cliby WA
Gynecol Oncol; 2019 Feb; 152(2):223-227. PubMed ID: 30503050
[TBL] [Abstract][Full Text] [Related]
18. Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer.
van der Zanden V; van Soolingen NJ; Viddeleer AR; Trum JW; Amant F; Mourits MJE; Portielje JEA; van den Bos F; de Kroon CD; Kagie MJ; Oei SA; Baalbergen A; van Haaften-de Jong ALD; Houtsma D; van Munster BC; Souwer ETD
Gynecol Oncol; 2021 Aug; 162(2):360-367. PubMed ID: 34112514
[TBL] [Abstract][Full Text] [Related]
19. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer.
Eng OS; Raoof M; Blakely AM; Yu X; Lee SJ; Han ES; Wakabayashi MT; Yuh B; Lee B; Dellinger TH
J Surg Oncol; 2018 Jul; 118(1):121-126. PubMed ID: 29878375
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of peritoneal cancer index in primary advanced ovarian cancer.
Llueca A; Escrig J;
Eur J Surg Oncol; 2018 Jan; 44(1):163-169. PubMed ID: 29198495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
